Key Discussions on Biosimilars 2019 Current regulatory status of biosimilar medicines in the EU Market access and regulatory developments Sustainability of the biosimilar medicines sector Advances and convergence of regulatory science Regulatory requirements, scientific and operational challenges Biosimilar Development and Manufacturing Pharmacovigilance Clinical Trials Legal Considerations on Biosimilars FDA-Approved biosimilar products Prescribing biosimilar and generics drugs
Sign up and follow your favorite conferences.